中东和非洲制药业务洞察

Thirty-Eighth Edition Report Release Date: February 2026Analytical Timeframe: MAT Sep 2025 Disclaimer IQVIA is not an “authorised person” for the purposes of the Financial Services and Markets Act 2000 (“FSMA”) anddoes not provide investment advice or carry on any other regulated activity under Part II of the FSMA 2000 The forecasts, projections, and related information contained herein are made and provided subject to theassumptions, methodologies, caveats, and variables described in this report and are based on third party sources This report, in part or in whole, is not intended to constitute investment advice, and is not a recommendation topurchase or not purchase, an endorsement of, or an opinion as to the value of, any security or any investment As with any attempt to estimate future events, the forecasts, projections, conclusions, and other informationincluded herein are subject to certain risks and uncertainties, and are not to be considered guarantees of any This report shall not be published, nor shall any public references to IQVIA be made regarding these services or thisreport, without IQVIA’ prior written approval. When so provided, this report and the information herein must always This report is subject to the IQVIA General Terms and Conditions Agenda •Newsletter report summary•Regional summary and analysis•Spotlight on new offering•Appendix Business insights snapshot MAT Q3 2025:Many countries have witnessed high growth in 2025 Among the key countries, KSA saw growth of 20.7% and continues tolead, accounting for 36.9% of sales in MEA Region South Africa United Arab Emirates (UAE) •UAE grew by 11.89% PPG (3rdfastest growing country inMEA region**)accounting for $5.08 B sales•Top 10 TAsaccount for49.1%of total sales, whereinNewer Gen Type II Antidiabetics TA is growing at7.0% PPG•Top 10 corporationsaccount for47% sharein sales withPfizerbeing the fastest growing at20.7% PPG; mainly •South Africa has grown by 1.41% PPG accounting for$3.6 B saleswith theretail channel accounting for 84.6%of total sales•Cough & Cold Preparations TA continues to be Top TA at-3.6% PPG and 6.1% share•Top 10 corporationsaccount for50.9%share in sales.Adcock Ingram, a local firm, is leading with9.8%share Egypt (EGY)* Saudi Arabia (KSA) •Egypt volume sales has increased by 6.98% PPGdrivenby growth fromRetail channel (5.85% PPG) accountingfor 81.1% of country’s Units sales•Systemic Antibacterialsis the top TA in Egypt with10.2%Units share whileDermatological Anti-Infectives (12.1%PPG) is the fastest growingamongst the top 10 TAs•Top 10 corporations account for 41.3% sharein volume •Saudi Arabia has grown by 20.66% PPG, making it thefastest growing country in MEA, with sales valued at$15.02 B•Hospital channel (Hospitals + LPO) grew by 26.94% PPGand accounting for50.8% of total sales•Top 10 corporationsaccount for43.2%share in sales.Hikma Pharmais leading with6. 8%shareand30.5%PPG Algeria business in MEA is growing at 5.28% PPG mainly driven bylocal/regional players with 11.64% PPG Algeria (ALG) Fr. West Africa (FWA) Morocco (MOR) Kuwait (KWT) •Kuwait sales increased by 8.69% PPG accounting for$1.8 B salesdriven by hospital channel with13.74% PPG•Top 10 corporationsaccount for52.8%share in sales withNovartis, although declining,leading the business with6.61%share and decreased by-13.6%PPG.Eli Lilly (13.4%PPG)is the 2ndandSanofi at PPG 1.04%the 3rdlargestshare holding(6.4%)among top 10 corporations•Novartisgrowth is driven by high growth products like •Morocco retail channel hasincreased by 7.8% CAGR and10.6% PPG accounting for $2.0 B sales inMAT Q3 2025•This increase in sales is mainly attributed toMNCsthathavegrown by 11.14% PPG. Local/Regional corpsthathavegrown by 10.02%PPG while accounting for47.93% of total sales•Amongst the top 10 corporations,Bottu SAcontinues tolead, with5.3% sharein MAT Q3 2025.Pfizeris the fastestgrowing amongst top 10 at69.02%PPG Tunisia is growing at 11.18% PPG in MEA region •Tunisiahas grown by11.18% PPGaccounting for1.1 Bsales inMAT Q3 2025;•Hospital & Retailchannel grew by9.05% and 12.03% PPGrespectively;Retail channelaccounts for72.0%oftotal sales•Antihypertensive TAlead the sales; accounting for8.3%share in sales•Mediscontinues to be the leading corporation with6.81% •Lebanon retail channel unit sales increased by14.13% PPGreaching0.1 Bunit sales inMAT Q3 2025 •GSKis leading the Lebanon, with9.9% share and 0.1% PPGand Bayeris the fastest growing corporation with54% PPGamongst the top 10 corporations •Top 10 products for Bayer contribute 76.9%of the totalUnits sales amongst whichAspirin (29.6%), Bepanthen(238.7%), and Microgynon 30 (0.4%) PPGare fast growing Bahrain (BHR) Jordan (JOR) •Jordan retail channel sales increased by4.53% PPGaccounting for$0.4 BinMAT Q3 2025 •Bahrain sales decreased by18.29% PPGaccounting for$0.5 BinMAT Q3 2025 •Amongst the top 10 TAs,Anti-Epilepticsis the fastestgrowing TA with21.9% PPG•AlthoughHikma is leading the business w